Author type of review | Aim | Target population Setting | Country (number of studies) | N studies (N participants, age [years]) | PA/SB/HE Main outcomes inclusion criteria (device-measured/ self-reported/ both) | Intervention effectiveness for PA/SB/HE | AMSTAR Review Quality |
---|---|---|---|---|---|---|---|
Böhm et al. 2019 [47] Systematic review | To examine mHealth effectiveness for PA | children and/or adolescents NA | Australia (2), New Zealand (1), Canada (1), Israel (1), Poland (1), USA (1) | 7 (1164, 8–18) | PA Measured at least 1 PA-related variable as the outcome, (5/ 0/ 2) | PA: Ø | 6/11 medium |
Buckingham et al. 2019 [53] Systematic review | To examine mHealth effectiveness, feasibility and acceptability for PA and SB | NA workplace | USA (11), Australia (5), Canada (2), Netherlands (2), Belgium (1), Singapore (1), Finland (1), Norway (1), in multiple countries (1) | 30 publications, 25 (73,417, 18+) | PA/SB Any quantitative measure as primary outcome (21/ 4/ 0) | PA: 14/25 (56%) ↑ over time or vs control 6/25 (24%) Ø 3/25 (12%) ↓ over time or vs control 2/25 (8%) N/A Between-group difference for ↑ of around 847 (95% CI 68–1625) to 2183 (95% CI 992–3344) steps/day SB: 4/10 (40%) ↓over time or vs control 3/10 (30%) Ø 3/10 (30%) ↑over time or vs control | 7/11 medium |
Direito et al. 2017 [52] Systematic review and meta-analysis | To examine mHealth effectiveness for PA and SB To investigate relationship between the effect size and the nature of PA/SB outcomes and to code the BCTs | NA NA | USA (11), Australia (3), United Kingdom (3), Austria (1), Portugal (1), Ireland (1), Canada (1) | 21 (1701, 8.4–71.7) | PA/SB Duration or an estimate of energy expenditure (9/ 12/ 4) 1 not validated | PA: Total PA (7 studies): Ø SMD = 0.14, 95% CI − 0.12 - 0.41, I2 = 60% MVPA (9 studies):Ø SMD = 0.37, 95% CI − 0.03 - 0.77, I2 = 78% Walking (8 studies): Ø SMD = 0.14, 95%CI − 0.01 - 0.29, I2 = 0% SB (5 studies): ↓ SMD = − 0.26, 95% CI − 0.53 - − 0.00, I2 = 0% | 8/11 medium |
Ferrer et al. 2017 [51] Systematic review | To examine eHealth effectiveness for PA | NA | Not reported | 8 (458, all ages (M = 24.3, SD = 7,5) 93,4% female | PA Either as a primary or a secondary outcome measure (2/ 4/ 2) | PA: 2/5 (40%) RCTs ↑ group by time interaction for steps per week and light PA participation 0/5 (0%) RCTs reported significant main effects for group,4/5 (80%) RCTs reported significant main effects for time 1/3 (33%) non-RCTs studies ↑ group by time interactions for self-reported total PA 1/3 (33%) ↑ total steps during the social condition 1/3 (33%) ↑ self-reported mean minutes per week for all categories of PA | 4/11 medium |
Hamel et al. 2011 [56] Systematic review | To examine eHealth effectiveness for PA and HE | preadolescents and adolescents, 8–18 years NA | USA (11), Belgium (3) | 14 (6123 reported, 9–18) | PA PA or a PA-related health change as an outcome variable (2/ 10/ 2) | PA: 6/9 (67%) school-based interventions either ↑ PA in the intervention conditions and/or ↓ weight or BMI 2/5 (40%) home-based interventions either ↑ PA or ↓ BMI | 4/11 medium |
McIntosh et al. 2017 [50] Systematic review | To examine eHealth effectiveness for PA | young people attending school, college or university NA | USA (4), Netherlands (2), Thailand (1), Japan (1), Canada (1), Europe (1) | 10 (5352, young people) | PA Primary or secondary outcome (8/ 1/ 1) | PA: 8/10 (80%) ↑ over time or vs control | 5/11 medium |
Muellemann et al. 2018 [49] Systematic review | To examine eHealth effectiveness for PA To compare effectiveness with either no intervention or a non-eHealth intervention. | older adults, 55 years or above NA | USA (11), Netherlands (3), Belgium (1), Spain (1), Australia (1), New Zealand (1), Malaysia (1) | 25 publications, 20 (6671, 56–79.8 years) | PA Intervention effectiveness for any measure of PA (5/ 13/ 2) | PA: 9/9 (100%) web-based interventions ↑ over time or vs control 4/7 (57%) telephone-based interventions ↑ over time or vs control 3/4 (75%) text messaging-based interventions ↑ group over time or vs control | 7/11 medium |
Nour et al. 2016 [54] Systematic review and meta-analysis | To examine e/mHealth efficacy for HE | young adults, 18 to 35 years NA | USA (8), Australia (4), New Zealand (1), Malaysia (1) | 14 (7984, M = 20.8) | HE Primary or secondary aim of increasing FVI (0/ 14/ 0), 5 not validated | HE: FVI (8 studies): ↑ SMD = 0.22 95% CI 0.11–0.33, I2 = 68.5% Vegetable intake (5 studies): ↑ SMD = 0.15 95% CI 0.04–0.28, I2 = 31.4% | 9/11 high |
Rocha et al. 2019 [55] Meta-analysis | To examine eHealth effectiveness for HE To investigate the relationship of effectiveness and intervention characteristics (eHealth tool, tailoring, BCTs, and age group) | NA NA | USA (10), Netherlands (3), Scotland (1), Belgium (1), Portugal (1), Italy (1), Sweden (1), New Zealand (1) | 19 (6894, M = 4,5 to 57,75) | HE Reporting FVI results quantitatively (0/ 19/ 0), 5 not validated | HE: FVI (19 studies): ↑ g = 0.26 95% CI 0.17, 0.35, I2 = 62.77, p < .001 | 6/11 medium |
Schoeppe et al. 2016 [57] Systematic review | To examine mHealth effectiveness for PA, SB and HE | children and/or adults NA | USA (9), Australia (6), Canada (3), Switzerland (2), Netherlands (2), Ireland (2), Italy (1), Israel (1), New Zealand (1) | 30 publications, 27 (2699, 8–71) | PA/SB/HE Efficacy for behavior change. All types and units of measurements (8/ 13/ 6) | PA SB and/or HE: 19/27 (70%) ↑ in behavioral and related health outcomes either over time or vs control 5/10 (50%) ↑ single health behavior interventions vs control 7/17 (41%) ↑ multiple health behavior interventions vs control 8/13 (62%) ↑app in conjunction with other intervention strategies vs control 5/14 (36%) ↑ stand-alone app interventions vs control | 4/11 medium |
Stephenson et al. 2017 [48] Systematic review and meta-analysis | To examine e/mHealth for SB To identify the BCTs used within interventions | adults, 18 years or above NA | Not reported | 17 (1967, M = 20,4 - 64,1) | SB Device-measured or self-reported or proxy measure of SB (8/ 6/ 3) | SB (15 studies): ↓ −41.28 min/day 95% CI −60.99 - − 21.58, I2 = 77% at end point follow-up | 5/11 medium |